Your browser is no longer supported. Please, upgrade your browser.
Settings
CODX [NASD]
Co-Diagnostics, Inc.
Index- P/E5.34 EPS (ttm)1.56 Insider Own0.10% Shs Outstand28.79M Perf Week-0.36%
Market Cap248.41M Forward P/E15.97 EPS next Y0.52 Insider Trans-78.76% Shs Float27.11M Perf Month-15.14%
Income46.20M PEG- EPS next Q0.21 Inst Own27.00% Short Float7.93% Perf Quarter-9.83%
Sales96.30M P/S2.58 EPS this Y510.30% Inst Trans1.76% Short Ratio1.99 Perf Half Y-8.84%
Book/sh3.03 P/B2.76 EPS next Y-46.63% ROA61.70% Target Price- Perf Year-31.11%
Cash/sh2.43 P/C3.43 EPS next 5Y- ROE65.30% 52W Range7.01 - 20.69 Perf YTD-10.22%
Dividend- P/FCF4.76 EPS past 5Y55.00% ROI62.40% 52W High-59.63% Beta-1.81
Dividend %- Quick Ratio18.20 Sales past 5Y495.00% Gross Margin83.50% 52W Low19.12% ATR0.36
Employees37 Current Ratio19.10 Sales Q/Q14.20% Oper. Margin52.00% RSI (14)35.01 Volatility3.23% 4.20%
OptionableYes Debt/Eq0.00 EPS Q/Q-36.10% Profit Margin48.00% Rel Volume0.31 Prev Close8.51
ShortableYes LT Debt/Eq0.00 EarningsAug 12 AMC Payout0.00% Avg Volume1.08M Price8.35
Recom2.30 SMA20-6.29% SMA50-14.87% SMA200-19.41% Volume329,808 Change-1.88%
Mar-29-21Downgrade Maxim Group Buy → Hold
May-20-20Upgrade Maxim Group Hold → Buy
May-18-20Reiterated H.C. Wainwright Buy $20 → $35
Mar-09-20Reiterated H.C. Wainwright Buy $4 → $20
Mar-03-20Downgrade Maxim Group Buy → Hold
Oct-13-21 08:00AM  
Oct-06-21 10:54AM  
Sep-27-21 09:30AM  
Sep-23-21 09:30AM  
Sep-21-21 04:15PM  
09:30AM  
07:35AM  
Sep-20-21 05:03PM  
Sep-16-21 09:30AM  
Sep-13-21 06:30AM  
Sep-08-21 09:30AM  
Aug-23-21 09:30AM  
Aug-14-21 03:19AM  
Aug-13-21 05:47PM  
04:21PM  
02:03AM  
Aug-12-21 04:01PM  
Aug-04-21 11:30AM  
Jul-22-21 06:28PM  
09:30AM  
Jun-18-21 12:11PM  
10:30AM  
Jun-15-21 09:30AM  
May-15-21 03:45AM  
May-13-21 02:30PM  
May-04-21 09:30AM  
Apr-29-21 09:30AM  
Apr-28-21 09:30AM  
Apr-27-21 05:06AM  
Apr-20-21 09:30AM  
Mar-31-21 09:30AM  
Mar-30-21 05:18PM  
01:13AM  
Mar-29-21 04:42PM  
04:09PM  
02:14PM  
Mar-26-21 10:40AM  
06:00AM  
Mar-25-21 04:19PM  
04:01PM  
02:30PM  
Mar-18-21 08:30AM  
Mar-16-21 09:30AM  
Mar-14-21 03:18AM  
Mar-13-21 01:44AM  
Mar-10-21 09:30AM  
Mar-08-21 09:30AM  
Mar-02-21 09:30AM  
Feb-25-21 09:30AM  
Feb-24-21 03:22PM  
08:03AM  
Feb-23-21 08:36PM  
09:30AM  
Feb-17-21 12:44PM  
Feb-16-21 09:30AM  
Feb-10-21 01:30PM  
Feb-05-21 06:53AM  
Jan-30-21 12:00AM  
Jan-28-21 09:30AM  
Jan-25-21 05:35PM  
Jan-21-21 12:34AM  
Jan-09-21 08:29AM  
Jan-07-21 09:30AM  
Jan-06-21 09:30AM  
Jan-01-21 06:10AM  
Dec-22-20 09:30AM  
Dec-14-20 09:30AM  
Dec-10-20 12:44PM  
Dec-01-20 12:22PM  
Nov-25-20 03:40PM  
01:00PM  
Nov-24-20 08:00AM  
Nov-22-20 01:52AM  
Nov-17-20 04:43PM  
12:18PM  
09:56AM  
06:30AM  
Nov-16-20 04:27PM  
04:01PM  
Nov-11-20 09:13AM  
06:30AM  
Nov-10-20 06:30AM  
Nov-09-20 10:02AM  
08:02AM  
Nov-02-20 04:45PM  
Oct-29-20 10:15PM  
Oct-23-20 07:20AM  
Oct-17-20 09:20AM  
Oct-08-20 09:28AM  
Oct-07-20 08:39AM  
Oct-05-20 09:18AM  
Oct-02-20 10:55AM  
10:41AM  
06:30AM  
Sep-28-20 03:08PM  
Sep-24-20 11:36AM  
08:15AM  
06:30AM  
Sep-18-20 08:21AM  
Sep-11-20 02:00PM  
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Durenard EugeneDirectorSep 08Sale10.462,00020,9100Sep 22 11:37 AM
BENSON REED LGeneral CounselMay 19Option Exercise2.63108,334284,917108,334May 21 12:43 PM
BENSON REED LGeneral CounselMay 19Sale8.53108,334923,6280May 21 12:43 PM
Egan Dwight HChief Executive OfficerJan 15Option Exercise2.6350,000131,50050,000Jan 20 06:48 PM
Egan Dwight HChief Executive OfficerJan 15Sale11.0038,046418,5060Jan 20 06:48 PM
SERBIN RICHARD SDirectorJan 14Sale10.2910,000102,9002,500Jan 15 05:14 PM
Durenard EugeneDirectorJan 13Sale10.0910,500105,9452,000Jan 15 01:32 PM
NELSON JAMES BDirectorJan 13Sale10.1312,500126,6310Jan 15 01:29 PM
SERBIN RICHARD SDirectorDec 14Sale10.1017,000171,7000Dec 15 06:46 PM
Durenard EugeneDirectorDec 10Sale10.1510,000101,5000Dec 14 02:35 PM
BENSON REED LCFO and SecretaryNov 25Option Exercise1.10100,000110,000100,000Nov 30 10:47 AM
BENSON REED LCFO and SecretaryNov 25Sale10.5089,524940,0020Nov 30 10:47 AM
Egan Dwight HChief Executive OfficerNov 24Option Exercise1.1050,00055,00050,000Nov 25 08:56 AM
Egan Dwight HChief Executive OfficerNov 24Sale10.5144,764470,4700Nov 25 08:56 AM
Egan Dwight HChief Executive OfficerNov 23Option Exercise1.1080,00088,00080,000Nov 25 08:56 AM
Egan Dwight HChief Executive OfficerNov 23Sale10.4471,569747,1800Nov 25 08:56 AM
Egan Dwight HChief Executive OfficerNov 20Option Exercise1.1020,00022,00020,000Nov 25 08:56 AM
Egan Dwight HChief Executive OfficerNov 20Sale11.0918,017199,8090Nov 25 08:56 AM